# 肿瘤学市场中的人工智能 > 肿瘤学中的人工智能市场研究报告按应用（诊断、治疗规划、药物发现、预后）、按技术（机器学习、深度学习、计算机视觉、自然语言处理）、按癌症类型（肺癌、乳腺癌、结直肠癌、前列腺癌、淋巴瘤）、按数据类型（影像数据、基因组数据、临床数据、患者报告数据）、按部署模型（基于云的、本地的、混合的）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 预测到2035年 - **Forecast Period:** 2025 - 2035 - **CAGR:** 29.87% - **2024:** $ 22.69 Billion - **2025:** $ 29.47 Billion - **2035:** $ 402.33 Billion - **Key Players:** IBM (US), Siemens Healthineers (DE), Philips (NL), GE Healthcare (US), Tempus (US), CureMetrix (US), PathAI (US), Zebra Medical Vision (IL), Freenome (US) **Report ID:** MRFR/HC/27956-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/ai-in-oncology-market-29682 --- ## Market Summary ## **AI in Oncology Market Overview** As per MRFR analysis, the AI in Oncology Market Size was estimated at 22.69 (USD Billion) in 2024. The AI in Oncology Market Industry is expected to grow from 29.47 (USD Billion) in 2025 to 309.79 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 29.87% during the forecast period (2025 - 2034). Source Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Key AI in Oncology Market Trends Highlighted** The proliferation of AI-powered technologies in healthcare has significantly impacted the field of oncology. The integration of AI into oncology has facilitated the development of novel therapies, enhanced diagnostic capabilities, and streamlined treatment planning. Recent trends in AI in the oncology market include the increasing adoption of machine learning and deep learning algorithms for tumor detection, classification, and prediction of treatment outcomes. Moreover, advancements in AI-driven drug discovery and development are transforming the pharmaceutical industry, leading to the identification of potential drug candidates and personalized treatment approaches. Key market drivers include the rising prevalence of cancer, the growing need for personalized medicine, and the increasing demand for efficient and cost-effective healthcare solutions. Opportunities for further exploration and capture lie in the integration of AI with other cutting-edge technologies, such as genomics and imaging techniques, to enhance clinical decision-making and improve patient outcomes. ## **AI in Oncology Market Drivers** ### **Rising Prevalence of Cancer** Cancer is a leading cause of death worldwide, with an estimated 19.3 million new cases and 10.0 million deaths in 2020. The increasing incidence of cancer is attributed to factors such as population growth, aging, and unhealthy lifestyles. The rising prevalence of cancer is driving the demand for advanced and effective treatment options, including AI-powered oncology solutions. AI algorithms can analyze large volumes of patient data to identify patterns and predict disease progression, enabling personalized and targeted treatment strategies. This can lead to improved patient outcomes, reduced healthcare costs, and increased access to life-saving therapies. ### **Technological Advancements in AI** The rapid advancements in AI technology are revolutionizing the healthcare industry, including the field of oncology. AI algorithms are becoming increasingly sophisticated, enabling them to handle complex data analysis tasks and make accurate predictions. The development of new AI techniques, such as deep learning and machine learning, has opened up new possibilities for cancer diagnosis, prognosis, and treatment. AI-powered tools can analyze medical images, such as MRI and CT scans, to identify tumors and classify them based on their characteristics. This can assist radiologists in making more accurate diagnoses and determining the most appropriate treatment options. ### **Government Initiatives and Funding** Governments around the world are recognizing the potential of AI in improving healthcare outcomes and reducing healthcare costs. They are implementing initiatives and providing funding to support the development and adoption of AI-powered oncology solutions. For instance, the US National Cancer Institute (NCI) has launched several programs to accelerate the integration of AI into cancer research and clinical practice. These initiatives aim to foster collaboration between researchers, clinicians, and industry partners to develop and validate AI algorithms for cancer detection, diagnosis, and treatment. ## **AI in Oncology Market Segment Insights** ### **AI in Oncology Market Application Insights** The Application segment of the AI in Oncology Market is expected to witness significant growth in the coming years. Diagnosis held the largest share of the market in 2023, with a valuation of 4.02 USD billion. AI-powered diagnostic tools have revolutionized cancer detection by enhancing accuracy and efficiency. For instance, AI algorithms can analyze complex medical images and identify patterns invisible to the human eye, leading to earlier and more precise diagnoses. Treatment Planning is another key application, with a projected market size of 2.93 USD billion in 2023. AI algorithms can personalize treatment plans based on individual patient data, including medical history, tumor characteristics, and genetic profiles. This tailored approach optimizes treatment outcomes and reduces side effects. Drug Discovery is also poised for growth, with an estimated market value of 2.41 USD billion in 2023. AI accelerates the identification and development of new cancer drugs by analyzing vast datasets of molecular and clinical information. By predicting drug efficacy and toxicity, AI streamlines the [Drug Discovery Services Market](../../../reports/drug-discovery-services-market-5870) process and improves the chances of success. Prognosis is another important application, with a projected market size of 1.83 USD billion in 2023. AI algorithms can predict the likelihood of cancer recurrence and survival rates, aiding in treatment decision-making. Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **AI in Oncology Market Technology Insights** Technology is a key segment in the  AI in Oncology Market. Machine learning, deep learning, computer vision, and natural language processing are the major technologies used in AI-driven oncology solutions. Machine learning algorithms can analyze large datasets of patient data to identify patterns and make predictions about disease progression and treatment response. Deep learning algorithms can be used to develop AI models that can interpret medical images, such as X-rays and CT scans, to identify cancer cells and other abnormalities. Computer vision techniques can be used to develop AI systems that can analyze patient videos and images to track disease progression and monitor treatment outcomes. Natural language processing algorithms can be used to develop AI systems that can understand and interpret medical text, such as patient records and clinical notes, to extract relevant information and provide insights for decision-making. The increasing adoption of these technologies in the development of AI-driven oncology solutions is expected to drive the growth of the Technology segment in the  AI in Oncology Market. ### **AI in Oncology Market Cancer Type Insights** Cancer Type Segment Insights and Overview The cancer type segment holds a significant share in the  AI in Oncology Market. Lung cancer, breast cancer, colorectal cancer, prostate cancer, and lymphoma are the major cancer types targeted by AI-driven solutions. The high prevalence of these cancers and the need for personalized treatment plans drive the demand for AI-powered tools. In 2023, lung cancer accounted for the largest market share, followed by breast and colorectal cancers. By 2032, the breast cancer segment is projected to grow at the highest CAGR, owing to the rising incidence rates and increasing adoption of AI-based diagnostic and therapeutic approaches. Prostate cancer and lymphoma also represent substantial market opportunities, with AI-powered solutions aiding in early detection, risk assessment, and treatment selection. ### **AI in Oncology Market Data Type Insights** The AI in Oncology Market is segmented based on Data Type into Imaging Data, Genomic Data, Clinical Data, and Patient Reported Data. Among these segments, Imaging Data is expected to hold the largest market share of around 45% by 2028. This is primarily due to the increasing adoption of imaging technologies such as MRI, CT scans, and PET scans in cancer diagnosis and monitoring. Genomic Data is also expected to witness significant growth due to the rising demand for personalized medicine and the development of targeted therapies based on genetic profiling. Clinical Data, which includes electronic health records, lab results, and treatment plans, is expected to contribute to the growth of the AI in the Oncology Market as it provides valuable insights into patient outcomes and treatment effectiveness.Patient Reported Data, which includes patient-reported symptoms, side effects, and quality-of-life measures, is expected to gain traction due to its potential to improve patient-centered care and treatment decision-making. Overall, the increasing adoption of AI technologies in oncology is expected to drive the growth of the AI Oncology Market in the coming years. **AI in Oncology Market Deployment Model Insights** The AI in Oncology Market is segmented based on deployment model into cloud-based, on-premises, and hybrid. Among these, the cloud-based segment is expected to hold the largest market share in 2023 and is projected to continue its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing adoption of cloud computing services by healthcare providers, which offers benefits such as scalability, flexibility, and cost-effectiveness. On the other hand, the on-premises segment is expected to witness a steady growth rate during the forecast period due to the need for data security and privacy concerns associated with cloud-based solutions. The hybrid segment is also expected to gain traction as it offers a combination of the benefits of both cloud-based and on-premises deployment models. ### **AI in Oncology Market Regional Insights** The AI in Oncology Market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East and Africa. North America is the largest regional market for AI in Oncology, owing to the presence of a large number of key players and the high adoption of advanced technologies in healthcare. Europe is the second largest regional market, followed by Asia Pacific. The Asia Pacific region is expected to witness the highest growth rate during the forecast period due to the increasing awareness about cancer and the rising adoption of AI in Oncology solutions in the region. In 2023, the AI in Oncology Market was valued at 13.46 billion USD and is expected to reach 141.4 billion USD by 2032, exhibiting a CAGR of 29.87% during the forecast period. Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **AI in Oncology Market Key Players and Competitive Insights** Major players in the AI Oncology Market are continuously focusing on the research and development of advanced AI technologies to enhance the accuracy and efficiency of cancer diagnosis and treatment. Leading AI in Oncology Market players are actively involved in strategic collaborations, partnerships, and acquisitions to expand their market reach and strengthen their product portfolio. Partnerships between AI in Oncology Market development companies and healthcare providers have become increasingly common, enabling the seamless integration of AI-powered solutions into clinical workflows. The competitive landscape is characterized by intense competition among established players and emerging startups, driving continuous innovation and pushing the boundaries of AI in Oncology Market technology. Insilico Medicine is a leading company in the AI in Oncology Market space, known for its pioneering work in applying AI to drug discovery and development. The company's end-to-end AI platform, known as Pharma. AI integrates cutting-edge techniques such as generative adversarial networks (GANs), deep learning, and reinforcement learning to identify novel drug targets, design new molecules, and predict their efficacy and safety. Insilico Medicine has established partnerships with major pharmaceutical companies, including Roche and Merck, to accelerate the development of new cancer therapies. Another key competitor in the AI in Oncology Market is IBM Watson Health. IBM's AI-powered Watson for Oncology solution provides clinicians with personalized treatment recommendations, clinical trial matching, and real-time guidance during cancer care. The platform leverages data from millions of patient records, scientific literature, and clinical trials to deliver evidence-based insights and support decision-making. IBM Watson Health has partnered with leading healthcare institutions worldwide, including MD Anderson Cancer Center and the Mayo Clinic, to implement Watson for Oncology in clinical practice. ### **Key Companies in the AI in Oncology Market Include** - Amazon Web Services - Google - [**Siemens Healthineers**](https://www.siemens-healthineers.com/perspectives/AI-cancer-care) - Insilico Medicine - NVIDIA - Oracle - Tencent - General Electric Healthcare - Alibaba - Microsoft - Baidu - IBM - Relay Therapeutics - Exscientia ## Ai In Oncology Market Industry Developments - **Q2 2025: AI researchers develop new technologies for cancer care** Researchers at Vanderbilt University Medical Center developed two new AI-powered technologies: MSI-SEER, which predicts microsatellite instability-high status from pathology slides, and a 3D imaging tool for advanced tissue analysis, both aimed at improving cancer diagnostics and personalized medicine. ## **AI in Oncology Market Segmentation Insights** ### **AI in Oncology Market Application Outlook** - Diagnosis - Treatment Planning - Drug Discovery - Prognosis ### **AI in Oncology Market Technology Outlook** - Machine Learning - Deep Learning - Computer Vision - Natural Language Processing ### **AI in Oncology Market Cancer Type Outlook** - Lung Cancer - Breast Cancer - Colorectal Cancer - Prostate Cancer - Lymphoma ### **AI in Oncology Market Data Type Outlook** - Imaging Data - Genomic Data - Clinical Data - Patient Reported Data ### **AI in Oncology Market Deployment Model Outlook** - Cloud-based - On-premises - Hybrid ### **AI in Oncology Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### 机器学习的进展 机器学习技术的快速进步正在改变肿瘤学市场中的人工智能。机器学习算法越来越能够处理和分析复杂的医疗数据，从而改善诊断和治疗结果。例如，人工智能系统现在可以识别影像数据中的模式，这些模式可能对人类临床医生来说是不可察觉的。这一能力不仅提高了癌症诊断的准确性，还促进了个性化治疗方案的制定。随着机器学习的不断发展，其在肿瘤学实践中的整合预计将扩大，推动肿瘤学市场的增长，并促进癌症护理的创新。 ### 癌症发病率上升 全球癌症的日益普遍是人工智能在肿瘤学市场的主要驱动因素。根据最近的统计数据，癌症病例预计将显著上升，估计到2040年，每年可能会有超过2700万例新的癌症病例。这一令人担忧的趋势需要创新的解决方案，例如人工智能，以增强早期检测和治疗选择。人工智能技术正在被整合到肿瘤学实践中，以分析大量数据集，提高诊断准确性和治疗效果。随着医疗系统应对日益增长的癌症负担，对人工智能驱动工具的需求可能会加剧，从而推动人工智能在肿瘤学市场的发展。 ### 增加对医疗技术的投资 对医疗技术的投资激增是肿瘤学人工智能市场的重要催化剂。各国政府和私营实体正在认识到人工智能在革命性癌症护理方面的潜力，这导致了对研究和开发的重大资金投入。报告显示，未来几年对人工智能医疗解决方案的投资预计将达到数十亿美元。这一资金的涌入可能会加速肿瘤学中人工智能应用的发展，从诊断工具到治疗优化。随着财务资源的日益可用，肿瘤学人工智能市场有望实现强劲增长，使得开发尖端解决方案以对抗癌症成为可能。 ### 人工智能创新的监管支持 监管机构越来越支持医疗保健中的人工智能创新，这是肿瘤学市场中人工智能的重要驱动力。旨在简化基于人工智能的医疗设备和软件的审批流程的举措正在实施，从而加快新技术进入市场的速度。这种监管环境鼓励公司投资于肿瘤学的人工智能解决方案，因为他们知道自己的产品可以更高效地到达医疗服务提供者和患者。随着法规的发展以适应人工智能带来的独特挑战，肿瘤学市场中的人工智能可能会经历加速增长，促进一个适合创新的环境。 ### 对远程医疗解决方案的需求不断增长 远程医疗解决方案的需求不断上升，正在显著影响肿瘤学中的人工智能市场。随着患者越来越多地寻求远程医疗选项，人工智能与远程医疗平台的整合变得至关重要。人工智能技术可以通过提供实时数据分析和决策支持来增强虚拟咨询。这一能力不仅改善了患者的治疗效果，还简化了医疗服务提供者的工作流程。预计远程医疗的趋势将持续，特别是当患者优先考虑便利性和可及性时。因此，随着远程医疗解决方案的普及，肿瘤学中的人工智能市场可能会扩大，推动人工智能技术在癌症护理中的应用。 ## Future Outlook 肿瘤学市场中的人工智能预计将在2024年至2035年间以29.87%的年复合增长率增长，推动因素包括机器学习、数据分析和个性化医疗的进步。 **New opportunities:** - 开发基于人工智能的早期癌症检测诊断工具。 到2035年，肿瘤学中的人工智能市场预计将成为癌症护理的关键组成部分。 ## Segment Insights ### 按应用：诊断（最大）与药物发现（增长最快） 在肿瘤学市场中的人工智能应用领域，主要由诊断、治疗规划、药物发现和预后驱动。诊断占据了最大的市场份额，代表了整体市场的一个重要部分，因为人工智能技术越来越多地被用于提高早期癌症检测的准确性和速度。紧随其后，治疗规划和药物发现也在获得关注，其中药物发现因其加速新治疗和药物开发的潜力而成为一个重要领域。 诊断（主导）与药物发现（新兴） 诊断环节在肿瘤学市场中至关重要，利用先进的算法分析医学影像、病理报告和基因数据，以实现精准的癌症检测。其主导地位源于对及时和准确诊断的迫切需求，从而改善患者的治疗结果。相反，药物发现虽然目前处于新兴阶段，但正迅速获得关注。它利用人工智能简化新治疗化合物的发现过程，并优化临床试验设计，承诺通过减少新药上市的时间和成本来彻底改变治疗格局。 ### 按技术：机器学习（最大）与深度学习（增长最快） 肿瘤学中的人工智能市场以多样化的技术为特征，其中机器学习占据了最大的市场份额。该细分市场利用算法分析复杂的医疗数据，帮助诊断和个性化治疗。深度学习作为机器学习的一个高级子集，由于其处理庞大数据集和提高预测准确性的能力，正在迅速获得人气。其他显著的技术包括计算机视觉和自然语言处理，分别在医学成像和解读患者数据中发挥着重要作用。 技术：机器学习（主导）与深度学习（新兴） 机器学习目前是肿瘤学人工智能市场的主导技术，以其在临床决策和预测分析中的多功能性而闻名。它使医疗服务提供者能够利用历史数据制定量身定制的治疗计划。相比之下，深度学习作为一个关键参与者正在崛起，特别是在处理和分析医学图像方面，其准确性超过传统方法。这项技术能够从大量数据中自主学习，推动了其增长。这两种技术对于提高诊断性能至关重要，但它们的应用有所不同，机器学习更侧重于结构化数据分析，而深度学习则在非结构化数据解释方面表现出色，例如图像和文本。 ### 按癌症类型：肺癌（最大）与乳腺癌（增长最快） 在肿瘤学市场中，肺癌目前占据了相当大的市场份额，使其成为按癌症类型划分的最大细分市场。这一显著性主要归因于肺癌的高发病率和死亡率，迫切需要通过人工智能技术进行创新的诊断和治疗方法。另一方面，乳腺癌正迅速获得关注，市场份额不断增加，这得益于人们对早期检测和个性化治疗选择的认识提高。随着更多技术的出现，该细分市场有望实现显著增长。 肺癌（显性）与结直肠癌（新兴） 肺癌仍然是人工智能在肿瘤学市场中的主导癌症类型，这受到多种因素的推动，包括高发病率和对先进诊断解决方案的迫切需求。人工智能工具在肺癌诊断中的整合简化了流程，提高了患者的治疗效果，并缩短了治疗时间。相比之下，结直肠癌作为一个显著的细分市场正在崛起，这得益于筛查技术的进步和公众对风险因素的日益关注。向靶向疗法的转变以及人工智能在精准医学中的作用正在增强对结直肠癌的理解和管理，表明这一细分市场在肿瘤学领域获得关注的未来光明。 ### 按数据类型：影像数据（最大）与基因组数据（增长最快） 肿瘤学中的人工智能市场展示了多样化的数据类型分布，其中影像数据目前占据最大的市场份额。该细分市场利用先进的影像技术来辅助诊断和治疗规划。相比之下，基因组数据正迅速崛起为增长最快的细分市场，这得益于精准医学的进步以及对个性化治疗策略的日益关注。临床数据和患者报告数据也发挥着关键作用，但它们目前在这一领域中占据的份额较小。 影像数据（主导）与基因组数据（新兴） 影像数据在肿瘤学人工智能市场中仍然占据主导地位，通过 MRI、CT 和 PET 扫描等多种方式提供重要的洞察。这些技术增强了有效检测、监测和治疗各种癌症的能力。另一方面，基因组数据是一个新兴领域，通过对个体基因组的理解，正在革新治疗方案。基因组洞察的整合有助于靶向治疗，从而为改善患者结果提供潜力。随着技术的发展，这两个领域可能会继续扩大其影响力，影像数据在诊断中巩固其地位，而基因组数据则推动个性化医学向前发展。 ### 按部署模型：基于云的（最大）与本地部署（增长最快） 肿瘤学市场的人工智能正在经历部署模型的重大转变，基于云的解决方案因其可扩展性、灵活性和可访问性而主导市场。这种模型使肿瘤科能够利用先进的人工智能技术，而无需在基础设施上进行大量投资。尽管本地解决方案目前占有较小的市场份额，但在优先考虑数据安全和合规性的组织中，尤其是在敏感的医疗环境中，需求正在激增。 部署：基于云的（主导）与本地部署（新兴） 云端部署模型在肿瘤学市场中的特点是能够提供持续的实时数据分析和机器学习能力，从而促进更快的诊断和治疗方案。对于可能缺乏显著IT资源的小型诊所而言，这种模型尤其具有优势。另一方面，现场系统在需要对敏感数据进行完全控制的大型医疗机构中越来越受到欢迎。这些新兴的现场解决方案强调增强的安全措施和定制设置，使其在日益严格的监管审查面前显得尤为吸引人。随着这两种模型的发展，混合解决方案也越来越受欢迎，旨在结合两者的最佳特性，同时满足不同组织的需求。 ## Regional Market Share Analysis 肿瘤学中的人工智能市场分为北美、欧洲、亚太地区、南美以及中东和非洲。北美是肿瘤学中人工智能最大的区域市场，这得益于众多关键参与者的存在以及医疗保健中先进技术的高采用率。欧洲是第二大区域市场，其次是亚太地区。 预计亚太地区在预测期内将见证最高的增长率，这主要是由于对癌症的认识不断提高以及该地区对肿瘤学人工智能解决方案的采用不断上升。 2023年，肿瘤学中的人工智能市场估值为134.6亿美元，预计到2032年将达到1414亿美元，预测期内的年均增长率为29.87%。 来源：初级研究，次级研究，_市场研究未来_数据库和分析师评审 ## Competitive Benchmarking 人工智能肿瘤市场的主要参与者持续专注于先进人工智能技术的研究与开发，以提高癌症诊断和治疗的准确性和效率。领先的人工智能肿瘤市场参与者积极参与战略合作、伙伴关系和收购，以扩大市场覆盖面并增强产品组合。 人工智能肿瘤市场开发公司与医疗服务提供者之间的合作变得越来越普遍，使得人工智能驱动的解决方案能够无缝集成到临床工作流程中。 竞争格局的特点是成熟企业与新兴初创公司之间的激烈竞争，推动着持续的创新并推动人工智能肿瘤市场技术的边界。 Insilico Medicine 是人工智能肿瘤市场领域的领先公司，以其在药物发现和开发中应用人工智能的开创性工作而闻名。该公司的端到端人工智能平台被称为 Pharma。 人工智能集成了前沿技术，如生成对抗网络（GANs）、深度学习和强化学习，以识别新药靶点、设计新分子并预测其有效性和安全性。Insilico Medicine 已与包括罗氏和默克在内的主要制药公司建立了合作关系，以加速新癌症疗法的开发。 人工智能肿瘤市场的另一个主要竞争者是 IBM Watson Health。IBM 的人工智能驱动的 Watson for Oncology 解决方案为临床医生提供个性化的治疗建议、临床试验匹配和癌症护理过程中的实时指导。 该平台利用来自数百万患者记录、科学文献和临床试验的数据，提供基于证据的见解并支持决策。 IBM Watson Health 已与全球领先的医疗机构建立了合作关系，包括 MD 安德森癌症中心和梅奥诊所，以在临床实践中实施 Watson for Oncology。 ## Recent News & Developments - **2025年第二季度：人工智能研究人员开发癌症护理新技术**范德比尔特大学医学中心的研究人员开发了两种新的人工智能技术：MSI-SEER，它可以从病理切片中预测微卫星不稳定性高的状态，以及一种用于高级组织分析的3D成像工具，旨在改善癌症诊断和个性化医疗。 ## Report Scope | 2024年市场规模 | 226.9（十亿美元） | | --- | --- | | 2025年市场规模 | 294.7（十亿美元） | | 2035年市场规模 | 4023.3（十亿美元） | | 复合年增长率（CAGR） | 29.87%（2024 - 2035） | | 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 历史数据 | 2019 - 2024 | | 市场预测单位 | 十亿美元 | | 关键公司简介 | 市场分析进行中 | | 覆盖的细分市场 | 市场细分分析进行中 | | 关键市场机会 | 先进机器学习算法的集成提高了肿瘤学市场的诊断准确性。 | | 关键市场动态 | 人工智能在肿瘤学中的日益集成提高了诊断准确性和治疗个性化，推动了市场的发展。 | | 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 | ## Frequently Asked Questions **Q: 到2035年，肿瘤学领域人工智能的预计市场估值是多少？** A: 预计到2035年，肿瘤学领域的人工智能市场估值将达到4023.3亿美元。 **Q: 2024年肿瘤学领域人工智能的整体市场估值是多少？** A: 2024年肿瘤学人工智能的整体市场估值为226.9亿美元。 **Q: 在2025年至2035年的预测期内，肿瘤学领域人工智能的预期CAGR是多少？** A: 在2025年至2035年的预测期内，肿瘤学领域的人工智能市场预期年复合增长率（CAGR）为29.87%。 **Q: 在肿瘤学人工智能市场中，哪个应用领域的估值最高？** A: 治疗计划应用细分市场的估值最高，达到1200亿美元。 **Q: 推动肿瘤学市场人工智能的关键技术是什么？** A: 推动肿瘤学人工智能市场的关键技术包括深度学习，估值为1200亿美元。 **Q: 到2035年，预计哪种癌症类型的市场估值最高？** A: 乳腺癌预计将拥有最高的市场估值，达到1200亿美元。 **Q: 在肿瘤学市场中，预计哪种数据类型将占主导地位？** A: 临床数据预计将在肿瘤学人工智能市场中占主导地位，估值为1500亿美元。 **Q: 预计到2035年，哪种部署模型将占据最大的市场份额？** A: 预计本地部署模型将占据最大的市场份额，价值为1450亿美元。 **Q: 在肿瘤学人工智能市场中，关键参与者是谁？** A: 在肿瘤学人工智能市场中的主要参与者包括IBM、Siemens Healthineers和GE Healthcare。 **Q: 在肿瘤学市场中，药物发现部门的估值是多少？** A: 药物发现领域在肿瘤学中的人工智能市场的估值为800亿美元。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/ai-in-oncology-market-29682*